Aarti Pharmalabs Limited
Aarti Pharmalabs Limited (AARTIPHARM.BO) Stock Overview
Explore Aarti Pharmalabs Limited’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
64.3B
P/E Ratio
30.04
EPS (TTM)
$23.53
ROE
0.11%
AARTIPHARM.BO Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Aarti Pharmalabs Limited (AARTIPHARM.BO) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 42.61, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $1036.98.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 30.04 and a market capitalization of 64.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.